Related Experiment Video
Updated: Aug 13, 2025

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
Published on: June 11, 2020
COVID-19-associated myocardial injury: A case report
Tomonori Tadokoro1, Keiko Ohta-Ogo2, Yoshihiko Ikeda2
1Department of Cardiovascular Medicine, St. Mary's Hospital, Kurume, Japan.
Abstract:
Coronavirus disease 2019 (COVID-19) is often accompanied by pneumonia and can be fatal. We report a case of COVID-19-associated myocardial injury mimicking fulminant myocarditis. Endomyocardial biopsy revealed numerous von Willebrand factor-rich microthrombi with small myocardial necrotic areas, complement deposits in small vessels/microthrombi, and macrophage-predominant interstitial infiltration. These findings, distinct from those of typical lymphocytic myocarditis, show diffuse endothelial injury, complement activation, and activated macrophages as characteristic features of COVID-19-associated pathogenesis. Dysregulated serum cytokine profiles predicting severe/critical COVID-19-associated myocardial injury were also determined. This case emphasizes the occurrence of fatal cardiac manifestation with microthrombotic injury in the early stage of COVID-19.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis III: Medical Management
Acute Coronary Syndrome I: Introduction
Myocarditis IV: Nursing Management
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

